4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      TTK regulates proliferation and apoptosis of gastric cancer cells through the Akt‐mTOR pathway

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          TTK (also known as Mps1) is the core component of the spindle assembly checkpoint, which ensures proper distribution of chromosomes to daughter cells to maintain genome integrity and to balance growth and division. However, the function of TTK in tumorigenesis has not been extensively studied, especially in relation to the development of gastric cancer. In this study, survival and tumor recurrence data related to TTK expression level in gastric cancer patients were collected and analyzed. We observed that TTK expression was negatively correlated with survival and tumor recurrence in vivo. TTK was also upregulated in gastric cancer cells and was observed to be essential for the proliferation and survival of gastric cancer cells. Knockdown of TTK inhibited proliferation and increased apoptosis. Furthermore, we report that TTK regulates the proliferation and apoptosis of tumor cells through the Akt‐mTOR pathway. Knockdown of TTK inhibited activation of Akt‐mTOR signaling. In summary, our data indicate that TTK is involved in the regulation of gastric cancer proliferation and apoptosis.

          Abstract

          We report here that high TTK expression is correlated with lower survival rate and higher tumor recurrence in gastric cancer patients. Knockdown or inhibition of TTK in gastric cancer cells resulted in Akt‐mTOR dysregulation and enhanced apoptosis of cancer cells. Our data suggest that TTK is involved in the regulation of gastric cancer proliferation and apoptosis.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Kinase-targeted cancer therapies: progress, challenges and future directions

          The human genome encodes 538 protein kinases that transfer a γ-phosphate group from ATP to serine, threonine, or tyrosine residues. Many of these kinases are associated with human cancer initiation and progression. The recent development of small-molecule kinase inhibitors for the treatment of diverse types of cancer has proven successful in clinical therapy. Significantly, protein kinases are the second most targeted group of drug targets, after the G-protein-coupled receptors. Since the development of the first protein kinase inhibitor, in the early 1980s, 37 kinase inhibitors have received FDA approval for treatment of malignancies such as breast and lung cancer. Furthermore, about 150 kinase-targeted drugs are in clinical phase trials, and many kinase-specific inhibitors are in the preclinical stage of drug development. Nevertheless, many factors confound the clinical efficacy of these molecules. Specific tumor genetics, tumor microenvironment, drug resistance, and pharmacogenomics determine how useful a compound will be in the treatment of a given cancer. This review provides an overview of kinase-targeted drug discovery and development in relation to oncology and highlights the challenges and future potential for kinase-targeted cancer therapies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The Clinical Evidence Linking Helicobacter pylori to Gastric Cancer

            Gastric cancer has long been recognized to be accompanied and preceded by chronic gastritis, lasting decades. Arguably, the most important development in our understanding of gastric cancer pathogenesis over the past 50 years has been the realization that, for most cases of gastric cancer, Helicobacter pylori is the cause of the underlying gastritis. Gastritis can promote gastric carcinogenesis, typically via the Correa cascade of atrophic gastritis, intestinal metaplasia, and dysplasia. Nested case-control studies have shown that H pylori infection increases the risk of gastric cancer significantly, both of the intestinal and diffuse subtypes, and that H pylori is responsible for approximately 90% of the world’s burden of noncardia gastric cancer. Based largely on randomized studies in high gastric cancer prevalence regions in East Asia, it appears that primary and tertiary intervention to eradicate H pylori can halve the risk of gastric cancer. Some public health authorities now are starting screening and treatment programs to reduce the burden of gastric cancer in these high-risk areas. However, there is currently much less enthusiasm for initiating similar attempts in the United States. This is partially because gastric cancer is a relatively less frequent cause of cancer in the United States, and in addition there are concerns about theoretical downsides of H pylori eradication, principally because of the consistent inverse relationship noted between H pylori and esophageal adenocarcinoma. Nevertheless, establishing a link between chronic H pylori infection and gastric cancer has led to novel insights into cancer biology, the gastrointestinal microbiome, and on individual and population-based gastric cancer prevention strategies.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma.

              Here, we show that the anaplastic thyroid carcinoma (ATC) features the up-regulation of a set of genes involved in the control of cell cycle progression and chromosome segregation. This phenotype differentiates ATC from normal tissue and from well-differentiated papillary thyroid carcinoma. Transcriptional promoters of the ATC up-regulated genes are characterized by a modular organization featuring binding sites for E2F and NF-Y transcription factors and cell cycle-dependent element (CDE)/cell cycle gene homology region (CHR) cis-regulatory elements. Two protein kinases involved in cell cycle regulation, namely, Polo-like kinase 1 (PLK1) and T cell tyrosine kinase (TTK), are part of the gene set that is up-regulated in ATC. Adoptive overexpression of p53, p21 (CIP1/WAF1), and E2F4 down-regulated transcription from the PLK1 and TTK promoters in ATC cells, suggesting that these genes might be under the negative control of tumor suppressors of the p53 and pRB families. ATC, but not normal thyroid, cells depended on PLK1 for survival. RNAi-mediated PLK1 knockdown caused cell cycle arrest associated with 4N DNA content and massive mitotic cell death. Thus, thyroid cell anaplastic transformation is accompanied by the overexpression of a cell proliferation/genetic instability-related gene cluster that includes PLK1 kinase, which is a potential molecular target for ATC treatment.
                Bookmark

                Author and article information

                Contributors
                huanghx@zucc.edu.cn
                g_yang@zju.edu.cn
                Journal
                FEBS Open Bio
                FEBS Open Bio
                10.1002/(ISSN)2211-5463
                FEB4
                FEBS Open Bio
                John Wiley and Sons Inc. (Hoboken )
                2211-5463
                01 July 2020
                August 2020
                : 10
                : 8 ( doiID: 10.1002/feb4.v10.8 )
                : 1542-1549
                Affiliations
                [ 1 ] School of Medicine Zhejiang University City College Hangzhou China
                [ 2 ] Institute of Bioengineering Hangzhou Medical College Hangzhou China
                Author notes
                [*] [* ] Correspondence

                H. Huang, School of Medicine, Zhejiang University City College, Hangzhou 310015, China

                E‐mail: huanghx@ 123456zucc.edu.cn

                and

                G. Yang, Institute of Bioengineering, Hangzhou Medical College, Hangzhou 310013, China

                E‐mail g_yang@ 123456zju.edu.cn

                Author information
                https://orcid.org/0000-0002-3903-8116
                Article
                FEB412909
                10.1002/2211-5463.12909
                7396433
                32530571
                5b442891-968f-4b23-88a4-85d65c36d096
                © 2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 17 February 2020
                : 07 May 2020
                : 05 June 2020
                Page count
                Figures: 4, Tables: 2, Pages: 8, Words: 5007
                Funding
                Funded by: Zhejiang TCM Health Science and Technology Project
                Award ID: 2015KYB110
                Funded by: Zhejiang Provincial Natural Science Foundation
                Award ID: LY18H180010
                Funded by: State Administration of Traditional Chinese Medicine of Zhejiang Province Project
                Award ID: 2015ZQ022
                Funded by: National Natural Science Foundation of China
                Award ID: 81802975
                Funded by: Zhejiang Medical and Health Science and Technology Project
                Award ID: 2019KY361
                Award ID: 2020KY101
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                August 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.6 mode:remove_FC converted:02.08.2020

                akt‐mtor pathway,apoptosis,gastric cancer,ttk
                akt‐mtor pathway, apoptosis, gastric cancer, ttk

                Comments

                Comment on this article